Exploring new and existing treatments for Alzheimer's disease in diverse communities
Use and Impact of Novel and Repurposed Therapeutics for Alzheimer's Disease and Related Dementia in Diverse Populations
This study is looking at new and existing medications for Alzheimer's disease, especially for non-Hispanic Black communities who may have a harder time getting these treatments, and it aims to understand the challenges they face so that everyone can have fair access to effective care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Southern California NIH-funded |
| Lab location | 1 site (Los Angeles, UNITED STATES) |
| Project ID | NIH-11309206 on NIH RePORTER |
What this research studies
This research investigates the use of both novel and repurposed medications for Alzheimer's disease and related dementias, particularly focusing on non-Hispanic Black communities who are at higher risk. The study aims to understand the barriers these communities face in accessing these treatments, including issues related to trust in the medical system and structural racism. By engaging with community stakeholders, the research will gather qualitative and quantitative data to identify demand and access challenges for these therapeutics. The ultimate goal is to facilitate equitable access to effective treatments for Alzheimer's disease and related dementias.
Who could benefit from this research
Good fit: Ideal candidates for this research include non-Hispanic Black individuals at risk for or diagnosed with Alzheimer's disease or related dementias.
Not a fit: Patients who are not part of the non-Hispanic Black community or those without a risk of Alzheimer's disease or related dementias may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved access to effective Alzheimer's treatments for underserved populations, potentially reducing the burden of the disease.
How similar studies have performed: Previous research has shown that addressing access barriers in underserved communities can lead to improved health outcomes, indicating that this approach has potential for success.
Where this research is happening
Los Angeles, UNITED STATES
- University of Southern California — Los Angeles, United States (Active)
Researchers
- Principal investigator: Zissimopoulos, Julie M — University of Southern California
- Study coordinator: Zissimopoulos, Julie M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.